In what may go down as one of the most controversial—and most damaging—pieces of healthcare policy in decades, the U.S. Preventive Services Task Force just issued a recommendation that men should no longer get routine screenings for prostate cancer. They believe that the test—called PSA, for the prostate-specific antigen it measures—does more harm than good....Continue reading
Tag: American Urological Association
An Informed Decision
Richard J. Ablin, research professor of immunobiology at the University of Arizona College of Medicine, has been studying prostate cancer for over 40 years. After discovering the Prostate-Specific Antigen (PSA), an enzyme made by the prostate, and subsequent approval by the Food and Drug Administration in 1994, the PSA test is the most commonly used...